ALRAZI

Al Razi Medical Company

9572StocksTadawulConsumer Discretionary

Financials

	CurrentMar 10, 2026	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021
Market & Price
Market Capitalization	43.75M	89.68M	90.90M	—	—
Market Cap Growth	-51.9%	-1.3%	—	—	—
Enterprise Value	56.54M	98.22M	97.40M	—	—
Last Close Price	28.78	59.00	59.80	—	—
Valuation Multiples
PE Ratio	155.29	509.93	132.51	—	—
PS Ratio	0.68	1.46	1.48	—	—
PB Ratio	1.92	3.96	4.06	—	—
P/TBV Ratio	1.95	4.03	4.15	—	—
P/FCF Ratio	53.85	81.55	91.19	—	—
P/OCF Ratio	11.12	18.09	15.73	—	—
EV/Sales Ratio	0.88	1.60	1.59	—	—
EV/EBITDA Ratio	11.04	36.62	32.66	—	—
EV/EBIT Ratio	39.96	94.35	62.66	—	—
EV/FCF Ratio	69.60	89.31	97.71	—	—
Leverage & Capital
Debt / Equity Ratio	0.58	0.38	0.48	0.32	0.27
Debt / EBITDA Ratio	2.56	1.78	2.04	1.45	1.49
Debt / FCF Ratio	16.12	7.86	10.73	—	—
Net Debt / Equity Ratio	0.56	0.34	0.44	0.26	-0.05
Net Debt / EBITDA Ratio	4.08	2.88	3.30	1.68	-0.36
Net Debt / FCF Ratio	15.75	7.03	9.87	-9.51	0.43
Efficiency & Liquidity
Asset Turnover	1.34	1.42	1.39	1.27	—
Inventory Turnover	2.21	2.23	1.98	1.84	—
Quick Ratio	0.29	0.27	0.14	0.19	0.89
Current Ratio	1.56	1.92	1.79	2.07	2.61
Returns & Yields
Return on Equity (ROE)	+1.2%	+0.8%	+3.0%	+8.4%	—
Return on Assets (ROA)	+1.9%	+1.5%	+2.2%	+3.9%	—
Return on Invested Capital (ROIC)	+1.7%	+1.1%	+3.2%	+8.1%	+9.0%
Return on Capital Employed (ROCE)	+4.2%	+3.5%	+5.0%	+8.6%	+8.2%
Earnings Yield	+0.6%	+0.2%	+0.8%	—	—
FCF Yield	+1.9%	+1.2%	+1.1%	—	—
Dividend Yield	+5.5%	—	+2.7%	—	—
Payout Ratio	—	—	+351.7%	+93.8%	—
Total Shareholder Return	+5.5%	—	+2.7%	—	—

	CurrentMar 10, 2026	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021
Market & Price
Market Capitalization	43.75M	89.68M	90.90M	—	—
Market Cap Growth	-51.9%	-1.3%	—	—	—
Enterprise Value	56.54M	98.22M	97.40M	—	—
Last Close Price	28.78	59.00	59.80	—	—
Valuation Multiples
PE Ratio	155.29	509.93	132.51	—	—
PS Ratio	0.68	1.46	1.48	—	—
PB Ratio	1.92	3.96	4.06	—	—
P/TBV Ratio	1.95	4.03	4.15	—	—
P/FCF Ratio	53.85	81.55	91.19	—	—
P/OCF Ratio	11.12	18.09	15.73	—	—
EV/Sales Ratio	0.88	1.60	1.59	—	—
EV/EBITDA Ratio	11.04	36.62	32.66	—	—
EV/EBIT Ratio	39.96	94.35	62.66	—	—
EV/FCF Ratio	69.60	89.31	97.71	—	—
Leverage & Capital
Debt / Equity Ratio	0.58	0.38	0.48	0.32	0.27
Debt / EBITDA Ratio	2.56	1.78	2.04	1.45	1.49
Debt / FCF Ratio	16.12	7.86	10.73	—	—
Net Debt / Equity Ratio	0.56	0.34	0.44	0.26	-0.05
Net Debt / EBITDA Ratio	4.08	2.88	3.30	1.68	-0.36
Net Debt / FCF Ratio	15.75	7.03	9.87	-9.51	0.43
Efficiency & Liquidity
Asset Turnover	1.34	1.42	1.39	1.27	—
Inventory Turnover	2.21	2.23	1.98	1.84	—
Quick Ratio	0.29	0.27	0.14	0.19	0.89
Current Ratio	1.56	1.92	1.79	2.07	2.61
Returns & Yields
Return on Equity (ROE)	+1.2%	+0.8%	+3.0%	+8.4%	—
Return on Assets (ROA)	+1.9%	+1.5%	+2.2%	+3.9%	—
Return on Invested Capital (ROIC)	+1.7%	+1.1%	+3.2%	+8.1%	+9.0%
Return on Capital Employed (ROCE)	+4.2%	+3.5%	+5.0%	+8.6%	+8.2%
Earnings Yield	+0.6%	+0.2%	+0.8%	—	—
FCF Yield	+1.9%	+1.2%	+1.1%	—	—
Dividend Yield	+5.5%	—	+2.7%	—	—
Payout Ratio	—	—	+351.7%	+93.8%	—
Total Shareholder Return	+5.5%	—	+2.7%	—	—